Mqs Management LLC Cerus Corp Transaction History

Mqs Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$3.38 - $4.22 $77,310 - $96,524	22,873 Added 51.8%	67,030 $244,000
Q3 2022 Nov 09, 2022	BUY	$3.43 - $5.83 $151,458 - $257,435	44,157 New	44,157 $159,000
Q2 2022 Aug 05, 2022	SELL	$4.41 - $5.69 $132,723 - $171,246	-30,096 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$4.81 - $6.99 $96,248 - $139,869	20,010 Added 198.39%	30,096 $165,000
Q4 2021 Feb 11, 2022	BUY	$5.97 - $7.93 $60,213 - $79,981	10,086 New	10,086 $69,000

156

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $317M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Mqs Management LLC, based on Form 13F filings with the SEC.

Stay updated on Mqs Management LLC with notifications on news.